B. Wirk and J. Lim, “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”, J Hematol, Apr. 2025, doi: 10.14740/jh2046.